Although the underlying mechanisms of DHM in the prevention and treatment of NAFLD are complex, our findings indicate that DHM improves hepatic steatosis and IR via AMPK/PGC-1α or PPARα-inducing autophagy in a rat model and steatotic hepatocytes (Fig. 9). This evidence concerns the gene PPARGC1A and fatty liver disease.